Healthcare / Medical Care FacilitiesTokyo
$489.00
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 21%
FCF escenarios
weak_data · normalized FCF $415.8M · quality 45.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
55/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7.7B
P/E
11.2x
↓EV/EBITDA
5.0x
↓ROE
18.8%
↑Gross Margin
69.1%
↑Debt/Equity
0.50
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+13.9%
FCF CAGR
—
FCF margin
11.4%
FCF / Net income
1.31x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $8.55B · net income $744.4M · FCF $972.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $8.55B | $8.55B | $7.00B | $6.41B | $5.79B |
| Net Income | $744.4M | $744.4M | $505.6M | $377.6M | $201.8M |
| EBITDA | $1.63B | $1.63B | $1.41B | $1.08B | $738.6M |
| EPS | 46.13 | 46.13 | 30.30 | 22.64 | 12.07 |
| Gross Margin | 69.1% | 69.1% | 70.5% | 71.7% | 73.8% |
| Operating Margin | 12.0% | 12.0% | 10.4% | 8.6% | 6.1% |
| Net Margin | 8.7% | 8.7% | 7.2% | 5.9% | 3.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.50 | 0.50 | 0.09 | 0.05 | 0.05 |
| Current Ratio | 1.43 | 1.43 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $972.4M | $972.4M | $415.8M | $77.8M | $-383.0M |
| Returns | |||||
| ROE | 18.8% | 18.8% | 12.7% | 10.4% | 5.9% |
| Valuation | |||||
| P/E | 11.18 | 11.18 | 13.20 | 18.82 | 47.14 |
| EV/EBITDA | 4.98 | 4.98 | 3.96 | 5.58 | 12.14 |
| P/B | 1.99 | 1.99 | 1.68 | 1.95 | 2.78 |
| Growth & Yield | |||||
| Revenue Growth | 22.2% | 22.2% | 9.3% | 10.6% | — |
| EPS Growth | 52.2% | 52.2% | 33.8% | 87.6% | — |
| Dividend Yield | 3.9% | 3.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-2.0%
EPS terminal req.
$43.39
Spread vs growth
54.3%
5Y implied EPS CAGR
2.6%
EPS terminal req.
$52.50
Spread vs growth
49.6%
10Y implied EPS CAGR
6.2%
EPS terminal req.
$84.56
Spread vs growth
46.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-13.1%
Start / end P/E
19.4x → 10.6x
EPS bridge
30.30 → 46.13
Residual
-23.8%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.